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Using transient transfection assays, regulation properties of Varicella-Zoster 
Virus (VZV)-encoded IE63 protein were analyzed on several VZV immediate early 
(ORF4), early (ORF28) and late (ORF67) promoters. IE63 was shown to repress the 
basal activity of most of the promoters tested in epithelial (Vero) and neuronal (ND7) 
cells to various extents. Trans-repressing activities were also observed on 
heterologous viral and cellular promoters. Since a construct carrying only a TATA box 
sequence and a series of wild-type or mutated IL-8 promoters were also repressed 
by IE63, the role of upstream regulatory elements were ruled out. Importantly, the 
basal activity of a TATA-less promoter was not affected by IE63. By using a series of 
IE63 deletion constructs, amino-acids 151 to 213 were shown to be essential to the 
trans-repressing activity in Vero cells, while in ND7 cells, the essential region 
extended to a much larger carboxy-terminal part of the protein. We also showed that 
IE63 was capable of disrupting the transcriptional pre-initiation complex and of 
interacting with several general transcription factors. The central and carboxy-
terminal domains of IE63 are important for these effects. Altogether, these results 
demonstrated that IE63 protein is a transcriptional repressor whose activity is 
directed towards general transcription factors. 
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Varicella-Zoster-Virus (VZV) is a human alphaherpesvirus that causes 
chickenpox (varicella) and becomes latent in dorsal root ganglia (DRG). Upon 
reactivation from latency, VZV is responsible for zoster (shingles). The VZV genome 
is a double-stranded DNA molecule composed of 71 open reading frames (ORFs) 
encoding 68 proteins that seem to be regulated in a manner similar to other 
alphaherpesviruses. After entry into the cells, VZV genes are expressed in a 
temporal cascade. The immediate early (IE) genes are expressed first. They 
stimulate early (E) gene expression, providing most of the proteins necessary for viral 
DNA replication. After DNA synthesis has occurred, genes of the late (L) class 
encoding structural proteins are expressed. In contrast to Herpes Simplex Virus type 
1 (HSV-1), the VZV latency is characterized by the expression of several IE (ORFs 4, 
62 and 63) and E (ORFs 21, 29, 66) genes (Cohrs et al., 1996, Cohrs et al., 2003, 
Grinfeld and Kennedy, 2004, Mahalingam et al., 1996, Meier et al., 1993). However, 
the biochemical and molecular processes controlling latency and reactivation of VZV 
are still largely unknown. 
VZV open reading frames 63 and 70 (ORF63/70) encode a 278-amino-acid 
long protein with a predicted molecular mass of 30.5 kDa but produce an extensively 
modified 45 kDa protein in infected cells (Debrus et al., 1995). ORF63 is expressed 
as an IE protein (IE63) and exhibits a limited homology with the HSV-1 IE protein 
ICP22 (Davison and McGeoch, 1986, Davison and Scott, 1986) and the EHV-1 
EICP22 protein (Derbigny et al., 2000). IE63 most closely resembles HSV-1 Us1.5, 
which is a 274-amino-acid protein encoded by a gene that is co-linear with the HSV-1 
ICP22 (Baiker et al., 2004).  
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IE63 is of particular interest in VZV pathogenesis since it is abundantly 
expressed during acute infection as well as during latency (Debrus et al., 1995, 
Grinfeld and Kennedy, 2004, Kennedy et al., 2000, Mahalingam et al., 1996). During 
lytic infection, its localization is mostly nuclear but it can also be faintly detected in the 
cytoplasm. However, during latency, IE63 is almost exclusively localized in the 
cytoplasm of infected neuronal cells (Grinfeld and Kennedy, 2004, Lungu et al., 1998, 
Mahalingam et al., 1996). IE63 protein interacts with VZV IE62 protein (Baiker et al., 
2004, Lynch et al., 2002) and is essential for VZV replication (Baiker et al., 2004, 
Sommer et al., 2001) and latency (Cohen et al., 2004).  
Transcription of viral genes during a productive infection is mediated by 
interaction between viral activator or repressor proteins and various components of 
the cellular transcription machinery. This interaction is important for increasing or 
decreasing the assembly of the preinitiation complex (PIC) necessary for 
transcription of genes by RNA polymerase II (RNA POL II). Activators or repressors 
may act directly or indirectly on the PIC formation. The PIC is composed of the RNA 
POL II and general transcription factors (GTFs) (for recent review, see (Hahn, 2004) 
that can be attached on promoter templates in vitro (Buratowski, 1994, Grondin and 
DeLuca, 2000, Hampsey, 1998). In most cases, the recognition of promoters is 
mediated by TFIID through the binding of the TATA binding protein (TBP) subunit to 
TATA box elements. The action of several viral proteins has been shown to be 
directed toward the PIC assembly (Choy and Green, 1993, Grondin and DeLuca, 
2000, Gu et al., 1995, Huang and McCance, 2002, Jang et al., 2001, Kim et al., 
2003, Long et al., 1999, Manet et al., 1993). 
The gene regulatory properties of IE63 protein are not very well understood 
and remain controversial. Some authors have reported that IE63 protein could 
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repress the VZV IE62 promoter, stimulate the VZV thymidine kinase promoter but 
could not affect expression of late genes in Vero cells (Jackers et al., 1992). Another 
team suggested that expressed under the control of its own promoter, IE63 did not 
exert any regulatory properties on IE, E and L genes in the same cell line (Kost et al., 
1995). Conversely, IE63 was shown to up-regulate IE62 effect on VZV gI promoter in 
A3.01 cells, a CD4+ T-cell line and to interact with VZV IE62 protein (Lynch et al., 
2002). Recently, IE63 has been shown to exert important trans-repressive properties 
on VZV DNA polymerase gene (ORF28) promoter both in Vero and ND7 cells 
(Bontems et al., 2002). Therefore, an extensive series of transient transfection 
studies were performed in order to better understand IE63 gene regulatory properties 
and its mechanism of action. From the data presented in this paper, it appears that 
IE63 is capable of repressing the basal activity of several promoters and is able to 




IE63 is a transcriptional repressor targeting the TATA-box. For many 
years, the transcriptional regulatory properties of IE63 remained unclear, being 
described either as a transcriptional repressor or activator depending on the promoter 
tested or without any transcriptional effect (Jackers et al., 1992, Kost et al., 1995, 
Lynch et al., 2002). Recently, it was unambiguously shown that IE63 represses 
transcription initiated from the promoter controlling the VZV DNA polymerase gene 
(Bontems et al., 2002). In order to better characterize IE63 regulatory properties, we 
decided to extend this important observation to other VZV promoters and to compare 
IE63 activity in two cell lines where VZV leads to either a productive (monkey kidney 
epithelial cells, Vero) or non-productive (immortalized rat sensory neurons, ND7) 
cycle (Bontems et al., 2002). Vero and ND7 cells were transfected with a plasmid 
expressing IE63 together with various constructs (Table 1) where the reporter gene 
was under the control of autologous (Figure 1) as schematically represented in 
Figure 1A or heterologous viral and cellular promoters (Figures 2 and 3) as 
schematically represented in Figures 2A and 3A. Figure 1B and 1C show that in both 
Vero and ND7 cells, IE63 exerts transcriptional repression properties towards 
autologous VZV promoters belonging to two classes: ORF4 (p4-Luc) which encodes 
a gene regulator expressed as an IE protein, ORF 28 (pPOL-Luc) which encodes the 
viral DNA polymerase and is an E protein. The basal activity of these promoters was 
dose-dependently decreased with IE63 expression (pcDNA-IE63). IE63 did not show 
any repressive activity on the promoter belonging to the L class (p67-Luc) that 
controls expression of the glycoprotein I (Figure 1B and C). The presence of IE63 
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expression in the two cell lines was detected by western blot analysis (Figure 1B and 
C, lower part).  
In order to identify elements of these promoters that could help us to clarify the 
mechanism of repression mediated by IE63, sequence alignment analysis was 
carried out. The only motives shared by these promoters were a TATA-box and the 
Initiator element (InR) suggesting that IE63 could exert its repression on basal 
transcription initiation. Then, computer search for TATA-boxes was carried out on the 
promoter sequences using three different programs (Table 1). The scores were 
arbitrarily set on the same scale from 0 to 1; 1 being the best score. TATA-boxes of 
ORF4 (p4-Luc), ORF28 (pPOL-Luc), and ORF67 (p67-Luc) were previously mapped 
(Kinchington et al., 1994, Kost et al., 1995, Ling et al., 1992, Meier et al., 1994). As 
expected, sequence analysis of these 3 TATA-boxes revealed that ORF4 and 28 
obtained good scores, while the score of the ORF67 TATA box was much lower and 
could be classified as an atypical TATA-box (Table 1). We then extended the 
sequence analysis to other VZV promoters (Table 1). Strikingly, one of the lowest 
scores was obtained for a TATA-box from the ORF63 promoter (p63-Luc) which 
apparently had also an atypical TATA-box (Table 1). Transient transfection of Vero 
cells was therefore carried out with this promoter (Figure 1D). As shown in Figure 1D, 
IE63 exhibited a lesser repressing activity against its own promoter either under an 
extended or a short (163 bp) version (p63(163bp)-Luc) (Figure 1A). A similar 
behaviour was observed in ND7 cells transfected with the extended version of the 
ORF63 promoter (data not shown). 
We also analyzed different heterologous viral and cellular promoters known to 
have good TATA-boxes (Table 1). These were: the major IE promoter from human 
cytomegalovirus (CMV, pCMV-Luc) (Foecking and Hofstetter, 1986) and the HSV-1 
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UL44 (gC, pEL-Pgc-Luc) promoters (Lium and Silverstein, 1997). As expected, the 
scores obtained with the various programs were very close to 1 (Table 1). IE63 
repression property of these promoters was also examined (Figure 2). In that respect, 
these two promoters also had their basal activities down-regulated by IE63, both in 
Vero and ND7 cells (Figure 2B, C). The observation that both VZV and heterologous 
promoters could have their basal activity repressed by IE63 in a similar extend and 
independently of the cell type used is an interesting information that clarifies the 
regulatory properties of this viral protein.  
To further clarify the importance of TATA-box and/or InR elements in the 
repression mediated by IE63, we used a reporter plasmid whose transcription was 
under the control of a TATA box (pFR-Luc). The scores obtained by this sequence 
were quite good (Table 1). Figure 3B shows that IE63 reduced the activity of this 
promoter by about 60% both in Vero and ND7 cells, reinforcing the idea that IE63 
targeted TATA-boxes and/or InR. In order to confirm that IE63 targets only TATA-box 
motif, we have analyzed the effect of IE63 on the human polymerase alpha promoter 
(ph.POLα-Luc) which lacks this motive but bears an InR (Figure 3A and C). As 
expected, no TATA-box motive within this promoter was detectable by computer 
analysis (Table 1). Even without any detectable TATA-box, this promoter exhibited a 
high basal activity. Although IE63 protein was dose-dependently expressed (Fig 3c, 
lower part), the basal activity of the human polymerase alpha promoter was not 
decreased both in Vero and ND7 cells (Fig 3c). These results confirmed, on the one 
hand, that several upstream regulatory elements such as AP-2, AP-1, EF2, SP1, ATF 
and CAAT box were not involved in IE63 repression and, on the other hand, IE63 
protein targets only the TATA-box sequence. This experiment also ruled out the role 
of the InR sequence in the IE63-mediated repression. The lack of importance of 
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several upstream regulatory elements was further confirmed by using various 
constructs of the cellular IL-8 promoter which has been very well-characterized 
(Roebuck, 1999). The wild-type version of the promoter was dose-dependently 
repressed in both cell lines (Figure 3D, Table 1) and this repression was independent 
on the mutations of various upstream regulatory elements. This demonstrated that 
AP-1, NF-IL-6 and NF-κB elements were not required for IE63 activity.  
 
IE63 central and carboxy-terminal domains are important for repression. 
Recently, we showed that IE63 is a highly phosphorylated protein and the 
phosphorylation sites situated in the carboxy-terminal regions are necessary for 
repression (Bontems et al., 2002). In order to better characterize IE63 domains that 
are important for repression, IE63 deletion mutants were constructed: (i) IE63 ∆1-75 
with the amino-terminal region removed, (ii) IE63 ∆76-150 with the central region 
partly deleted, (iii) IE63 ∆151-213 with the region rich in CK1-CK2 phosphorylation 
sites was deleted and (iv) IE63 ∆214-278 where the carboxy-terminal domain 
containing two putative phosphorylation sites for CDK1 (Baiker et al., 2004, Bontems 
et al., 2002) and a nuclear localization signal were removed (Figure 4A). Western blot 
analysis demonstrated that these mutant proteins were stably expressed after 
transfection of Vero (Figure 4B) and ND7 (Figure 4C) with 1 to 3 µg of expression 
vectors. It should be noted that the removal of domain 151-213 of IE63 modified the 
electrophoretic migration of the protein which appeared somewhat smaller than 
expected (25 kDa instead of 34 kDa) (Figure 4B). This is likely due to the removal of 
a domain which is known to be highly phosphorylated in the wild-type protein 
(Bontems et al. 2002). Co-transfection of cells with IE63 wild-type or the deleted 
constructs and VZV DNA polymerase reporter vector (pPOL-Luc) led to unexpected 
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results (Figure 4D and E). Indeed, in Vero cells, the removal of either the amino-
terminal (IE63 ∆1-75), the second domain (IE63 ∆76-150) or the carboxy-terminal 
domain (IE63 ∆214-278) of IE63 did not alter its transrepression activity on the 
ORF28 (pPOL-Luc) promoter (Figure 4D) in comparison with IE63 wild-type. 
However, IE63 domain 3 was found essential for repression since its removal led to 
the loss of the repressive activity of the protein. Surprisingly, even the basal activity 
of the promoter was increased with this construct. In ND7 cells, the pattern of 
repression obtained with these mutant proteins was not identical (Figure 4E). The 
proteins lacking domain 3 (IE63 ∆150-213) or domain 4 (IE63 ∆214-278) turned out 
to be less efficient in repressing the ORF28 promoter, demonstrating the importance 
of the carboxy-terminal part of IE63 in this cell type (Figure 4E). Similar results were 
obtained with the IL-8 promoter (data not shown). 
 
IE63 co-localizes in the cell nucleus with TFIIE. As it is likely that IE63 
targeted TATA-boxes, we decided to characterize the cellular localization of IE63 with 
a component of the basal transcription machinery. In the classical model of 
transcriptional pre-initiation complex (PIC) assembly, the transcription factor TFIIE 
(composed of two subunits, TFIIEα and TFIIEβ) binds the RNA POL II at a late stage 
of initiation. Therefore, TFIIE was found to be a good marker for PIC localization in 
the cell nucleus. Confocal microscopy analysis was carried out on Vero and ND7 
cells transfected with the various constructs leading to wild-type or mutant IE63 
expression (Figure 5). Co-localization between IE63 and endogenous TFIIEα subunit 
was analyzed by the use of secondary antibodies linked to Fluorescein (TFIIE, in 
green) and Texas red (IE63, in red) (Figure 5A to 5F). IE63 wild- type protein was 
mainly observed in the nucleus of Vero and ND7 cells. As shown in Figure 5A and 
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5B, both IE63 and TFIIE are perfectly localized in the nucleus of the two cell types 
except in the nucleolus where IE63 was absent. Even if these results did not 
demonstrate on their own the interaction between IE63 and TFIIE, they showed that 
these proteins exhibited a very similar distribution in the nucleus. A similar co-
localization pattern was observed in cells expressing IE63 ∆1-75 and IE63 ∆76-150 
(data not shown).  
Analysis of the cells transfected with pcDNA-IE63 ∆151-213 revealed that the 
mutant protein expressed was mainly localised in the nucleus (Figure 5C and 5D). 
However, significantly less IE63 co-localization with TFIIE was observed compared 
with the wild-type protein. In the case of the IE63 ∆214-278, due to the removal of the 
nuclear localisation signal, this protein was exclusively localised in the cytoplasm of 
the two cell lines (Figure 5E and 5F). Surprisingly, although in all conditions TFIIE 
was exclusively located in the nucleus, a minor fraction of TFIIE could be detected in 
the cytoplasm of Vero cells expressing IE63 ∆214-278 (Figure 5E). In that case, the 
two proteins were shown to co-localize. This observation suggested that IE63 could 
partly sequester TFIIE or other associated GTFs in this cellular compartment. In ND7 
cells, IE63 was also mainly localized in the cytoplasm but not TFIIE (Figure 5F). 
Importantly, IE63∆214-278 and TFIIE were never co-localizing in the nucleus of ND7 
cells (Figure 5F). A positive control of nuclear co-localization in identical experimental 
conditions was carried out by co-transfecting IE63 and IE62 expression vectors in the 
two cell lines. IE62 was chosen since this protein was previously shown capable of 
interacting with IE63 (Lynch et al., 2002) (Baiker et al., 2004). As shown in Figures 
5G and 5H, IE62 (in green) and IE63 (in red) were detected in the cell nucleus and 
perfectly co-localized.  
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IE63 disorganizes the transcriptional pre-initiation complex. We then 
decided to examine whether IE63 could influence the PIC assembly when formed on 
a DNA probe. In that respect, a PIC assembly assay (Grondin and DeLuca, 2000) 
was performed involving a probe encompassing well-described transcription initiation 
sites (from HSV-1 gC or IL-8 promoters) bound to magnetic beads and extracts from 
Vero and ND7 cells either transfected or not with an IE63 expression vector. After 
PIC formation, the DNA-protein complexes were extensively washed and analyzed 
by SDS PAGE and silver-stained. Due to a weak binding efficiency of the Vero cell 
extracts to the gC or IL-8 probes, these experiments were only carried out with ND7 
cells. As shown in Figure 6A, SDS-PAGE analysis reveals several bands with a 
diminished intensity after IE63 expression (shown by the arrows), whereas others 
were totally unchanged (shown by stars). Examples of putative GTFs that could 
correspond to proteins having a reduced band intensity are listed in Figure 6A: TFIIE 
subunits: α (56 kDa), β (34 kDa), RNA POL II subunits: POLR2A (220 kDa), POLR2C 
(33 kDa), TAFs: TAF1 (250 kDa), TAF7 (55 kDa), TAF10 (30 kDa), TFIIH: 
polypeptide 2 (44 kDa), polypeptide 3 (34 kDa) and TFIIB (33 kDa). The mean 
reduction in the amount of putative transcription factors by IE63 expression was 
calculated after gel photodensitometry: TAF1: 39 %, POLR2A: 41 %, TFIIEα: 18 %, 
TFIIH2: 25 %, TFIIEβ: 50%. It should be noted that no increase in the band intensity 
was observed after IE63 expression in ND7 cells. In order to identify the factors 
incorporated within the pre-initiation complex whose concentration was lowered by 
IE63 on the gC probe, western blot analysis was carried out on several GTFs [RNA 
POL II, TFIIE, TFIIH, TFIID (TBP subunit) and TFIIB] and IE63. PIC assembly assays 
were performed in parallel on nuclear proteins bound to the probe and taken from 
cells transfected either with an empty vector (pcDNA3.1-) or with an IE63 expression 
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vector (pcDNA-IE63) (Figure 6B). Positive control was the protein input unbound to 
the probe (“not bound”). The first important information obtained by Western blot 
analysis was that only a very marginal fraction of IE63 could be found associated to 
the basal transcription machinery. The vast majority of IE63 was found in the flow 
through. Among the factors found to be associated with the pre-initiation complex, 
three of them (TFIIEα, TFIIH and TFIIB) had their concentration lowered when IE63 
was expressed (Figure 6B, central lane). The content in the RNA POL II large subunit 
(POLR2A) was also lowered but to a lesser extent. Finally, TBP was found to be 
unaffected by the presence of IE63. This last result could be explained by the weak 
interaction between these two proteins observed with a two-hybrid system (data not 
shown) and by the fact that TBP is buried inside the pre-initiation complex with no 
external exposure. We have also carried out a PIC assembly assay on the IL-8 probe 
and similar results were obtained (data not shown). Overall, these data demonstrated 
that IE63 is capable of interfering with several important factors of the transcriptional 
pre-initiation complex and therefore explained why IE63 represses transcription.  
 In order to correlate the data obtained in transient transfection assays with 
transcriptional pre-initiation complex assembly, PIC assays were also carried out on 
extracts from ND7 cells transfected with plasmids expressing IE63 where the 
domains 3 or 4 were removed and compared to wild-type IE63 or un-transfected cells 
(Figure 6C). Western blot analysis of the PIC content showed that TFIIE and TFIIB 
were not affected when domain 4 of IE63 was deleted (Figure 6C, lane 4). A slight 
decrease in the content of TFIIE was also observed with IE63 lacking the domain 3 
(Figure 6C). This demonstrates that the region of IE63 that encompassed most of the 
phosphorylation sites was crucial for removing these factors. Again, the IE63 deletion 
mutants were found stable and well-expressed in these conditions and the level of 
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TFIIE expressed was similar in cells that either expressed IE63 (wild-type or deletion 
mutants) or not (Figure 6D).  
To further confirm IE63 interaction with several GTFs, immunoprecipitation assays of 
IE63 were carried out (Figure 6E). ND7 cells were transfected with pcDNA-IE63-
IRES2-EGFP (allowing the expression of IE63 and GFP) and lysed 24 hours later. 
Western blot analyses of the proteins immunoprecipated with IE63 revealed the 
presence of TFIIH (Figure 6E). The presence of RNA POL II (POLR2A) and TFIIE in 
the immunoprecipitates could also be faintly detected (Figure 6E). As a control, IE63 
was also revealed by western blotting among the immunoprecipated proteins. 
Conversely, TFIIH immunoprecipitation also allowed the detection of IE63 in the 
transfected cells (Figure 6F). 
From these data, we can conclude that IE63 disorganizes the basal transcription 
initiation complex by interfering with the binding of several important GTFs on 
promoters through interaction with its phosphorylated domain leading to a repression 




In this paper, IE63 protein was shown to repress the basal activity of IE and E 
VZV promoters in a dose dependent manner. However, IE63 seems to repress the L 
promoter tested (gI promoter) and its own promoter to a far lesser extent. 
Heterologous promoters such as those controlling the CMV major IE gene and the 
human IL-8 were also repressed. When all the promoter sequences used were 
analyzed, the only element common to the tested promoters was the TATA-box. Its 
importance for IE63 repression was demonstrated by using promoters either bearing 
solely a TATA-box or having no TATA-box: IE63 efficiently repressed the first 
construct while it had no effect on the second. In conclusion, IE63 was shown to be a 
transcriptional repressor acting on different promoters but its efficiency depends on 
the presence and on the nature of the TATA-box. Several authors, including our 
group, have not always observed this property of IE63 to act as a transcriptional 
repressor (Jackers et al., 1992; Kost et al., 1995; Lynch et al., 2002). This can be 
explained by the use of less sensitive transfection technologies by several authors or 
by suspecting that IE63 repressive activities could not be observed in every cell type. 
By deletion analysis, we have also demonstrated that amino acids 151 to 213 of IE63 
were essential for the repression activity in Vero cells. This domain of IE63 
encompasses the S/T-rich region shown to be phosphorylated by both CK1 and –2. 
Therefore, it can be suspected that the active form of IE63 in these assays is the 
phosphorylated form. Unexpectedly, and for unknown reasons, the removal of this 
domain converts IE63 into a slight gene activator in Vero cells. In ND7 cells, the 
essential domain extended from the central part to the carboxy-terminal end of the 
protein. This carboxy-terminal domain encompasses a nuclear localization signal and 
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two amino-acids (T222 and S224) that could be phosphorylated by CDK1. Therefore, 
we can suspect that in undifferentiated neuronal cells the phosphorylation of these 
two amino-acids could be a pre-requisite for transcriptional repression. 
Several authors reported that viral proteins can interact with GTFs for gene 
transactivation or repression (Carrozza and DeLuca, 1996, Grondin and DeLuca, 
2000, Gu et al., 1995, Hampsey, 1998, Jang et al., 2001, Kawaguchi et al., 1997, 
Kim et al., 2003, Long et al., 1999). Three different mechanisms of repression via the 
basal transcription machinery have been proposed (for review, see Gaston and 
Jayaraman, 2003). The first involves a modification of the RNA POL II large subunit 
C-terminal domain (CTD). HSV-1 ICP22 and UL13 were shown capable of altering 
RNA POL II CTD phosphorylation to promote late viral transcription (Long et al., 
1999). The second mechanism is an interference with the binding of TBP to the 
TATA-box leading to a transcriptional repression. The adenovirus E1 protein 
represses transcription by making direct contact with TBP that interfere with the 
formation of the TBP-TATA complex (Song et al., 1997). Finally, a number of 
repressors either sequester GTFs or bind to GTF creating a steric hindrance 
preventing a correct PIC assembly. Our results revealed that this last mechanism 
may be applicable to IE63. The first step of PIC assembly is the TBP fixation on the 
TATA-box. We have first looked at this step and IE63 did not seem capable of 
targeting TBP. This was confirmed by (i) the demonstration that IE63 interacted 
poorly with TBP when using a two-hybrid system (data not shown) and (ii) TBP was 
not removed from the immobilized promoters in the presence of IE63. However, the 
content of RNA POL II, TFIIB, TFIIE and TFIIH bound to the probe was altered by 
IE63. Immunoprecipitation experiments confirmed these effects. Indeed, TFIIH, and 
to a lesser extent TFIIE and RNA POL II, were found to be immunoprecipitated with 
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IE63. Therefore, we believe that IE63 directly interacts with one of these proteins 
leading to the destabilisation of the PIC and the removal of several GTFs from the 
promoter. The PIC destabilisation explains how IE63 is a transcriptional repressor. 
These results confirmed those obtained using infected cells where IE63 was found to 
immunoprecipitate with RNA POL II (Lynch et al., 2002). Although the nature of the 
GTF(s) targeted by IE63 has not yet been unambiguously identified, it is obvious from 
the data presented above that IE63 sequestered one or several GTFs and by this 
way destabilized the PIC assembly.  
This hypothesis is reinforced by the observation made by confocal microscopy. 
Indeed, IE63 was always observed in the nucleus and co-localized with TFIIE, an 
important GTF. IE63 deleted of its region encompassing amino acids 151 to 213, 
important for repression, did not co-localize so clearly with TFIIE. Moreover, the 
expression of the cytoplasmic mutant of IE63 (IE63 ∆214-278) in Vero cells co-
localized with a small fraction of TFIIE present in the cytoplasm. This unexpected 
finding suggests that even present in the cytoplasm, IE63 could sequester a small 
fraction of neo-synthesized GTF(s). That could explain the preserved repressing 
capacity of this deleted IE63 protein. The cytoplasmic sequestration of TFIIE seems 
to be a special feature of IE63 expressed in Vero cells, since TFIIE was never found 
in the cytoplasm of ND7 cells. Interestingly, promoter repression by the carboxy-
terminal mutant of IE63 was partially lost in ND7 cells. 
In summary, this study demonstrated that IE63 is a transcriptional repressor 
effective on every promoter bearing a good TATA-box consensus. The repression 
occurs after IE63 had disorganized the formation of the pre-initiation complex by 
sequestering one or several GTFs. The capacity of IE63 to repress transcription has 
been observed in two different cell lines where VZV has a productive (Vero) or a non-
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productive cycle (ND7), demonstrating that this property is independent of the cell-
type and does not explain the non-productive infection observed in non differentiated 
neuronal cells by itself. To further clarify the role of IE63 in the latent infectious cycle, 
it would be interesting to analyze the repressive properties of this protein in 
differentiated neurons and to investigate the influence of phosphorylation by cellular 
kinases. 
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Materials and methods 
 
Plasmids- IE63 activity on different promoters was performed by transient 
transfection assays. Reporter plasmids with the luciferase (Luc) gene are under the 
control of VZV or heterologous promoters using the pGL3-Basic vector (Promega): 
p4-Luc (VZV ORF4 promoter), pPOL-Luc (VZV ORF28), p67-Luc (VZV ORF67), p63-
Luc (VZV ORF63). To construct the p4-Luc, the VZV ORF4 promoter was amplified 
by PCR from the p4-CAT (Defechereux et al., 1993) and then cloned in the Sma I 
and Bgl II sites. The pPOL-Luc was constructed as described previously (Bontems et 
al., 2002). To obtain the p67-Luc, pgI-CAT plasmid (Ling et al., 1992) was digested 
by Bgl II to excise the VZV ORF67 promoter and cloned in the pGL3-Basic vector into 
the Bgl II sites. The p63-Luc plasmid was generated by inserting the intergenic region 
between ORF62 and ORF63 in the pGL3-basic vector. A shorter version containing 
163bp of IE63 promoter driving luciferase gene was also performed; p63(163bp)-Luc. 
The pFR-Luc contains the luciferase gene and a TATA box sequence (Stratagene, 
USA). Plasmid pIL-8-Luc, a human IL-8 promoter fragment of 133bp and plasmid pIL-
8-NF-κB-mut-Luc, a human IL-8 promoter fragment of 133bp with the NF-κB site 
GGAATTTCCT (-80 to -71bp), mutated to TAACTTTCCT. Plasmid pIL-8-AP-1-mut-
Luc contained a human IL-8 promoter fragment of 133 bp with the AP-1 site 
TGACTCA (-126 to -120bp) mutated to TATCTCA. Plasmid pIL-8-NF-IL-6-mut-Luc 
[containing a human IL-8 promoter fragment of 133bp with the NF-IL6 site 
CAGTTGCAAATCGT (-94 to -81bp) mutated into AGCTTGCAAATCGT]. All these IL-
8-Luc plasmids were kindly provided by Dr. W. Vandenberghe and Dr. G. Haegeman 
(Ghent University, Ghent, Belgium). The pEL-Pgc-Luc contains the promoter of HSV-
1 UL44 (gC) gene and the luciferase reporter gene (Lium and Silverstein, 1997). 
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Plasmid ph.POLα-Luc contains the human DNA polymerase alpha promoter and was 
described elsewhere (Moon et al., 2001, Truscott et al., 2003). For the expression of 
IE63 or IE62, we cloned the ORF63 or ORF62 (under the control of the CMV 
promoter) in the pcDNA3.1- (InVitrogen) in order to obtain pcDNA-IE63 (Bontems et 
al., 2002) or the pcDNA-IE62. ORF63 was also cloned in the pcDNA-IRES2-EGFP 
(BD Biosciences, Clonetech) for dual expression of IE63 and EGFP (pcDNA-IE63-
IRES2-EGFP). Four plasmids expressing IE63 deletion mutants were constructed by 
PCR from pcDNA-IE63. The first, pcDNA-IE63∆1-75, led to the expression of IE63 
lacking, the first 75 amino acids. pcDNA-∆75-150, pcDNA∆151-213, pcDNA∆214-278 
are plasmids that express IE63 deleted of amino acids 75 to 150, 151 to 213 and 
214-278, respectively. The ORF63∆214-278 was also cloned in frame with the amino 
c-myc tag in the pCMV Tag3 (Stratagene) to obtain the pmyc-IE63∆214-278. All 
these expression constructions were sequenced. 
 TATA-box analysis – The promoter sequences tested were submitted to 
three different software that search for the core promoter and/or the TATA-box (the 
score was reported on a scale between 0.5 and 1.0): 
http://www.fruitfly.org/seq_tools/promoter.html (Reese, 1996), http://tfbind.ims.u-
tokyo.ac.jp (Heinemeyer et al., 1998) , http://motif.genome.ad.jp/ (Heinemeyer et al., 
1999).  
Antibodies – The antibodies used in this work are against -IE63 (monoclonal 
and polyclonal, (Bontems et al., 2002, Debrus et al., 1995, Kennedy et al., 2001)), -
TBP (polyclonal, Santa Cruz Biotechnology, SC-273), -TFIIB (monoclonal, 
Transduction Laboratories, T41520), -TFIIEα (polyclonal, Santa Cruz Biotechnology, 
SC-237), TFIIH –CDK7 (monoclonal, Santa Cruz Biotechnology, SC-7344) and RNA 
POL II largest subunit (monoclonal, Santa Cruz Biotechnology, sc-17798), -c-Myc 
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epitope (monoclonal, Santa Cruz Biotechnology, sc-40), -IE62 (polyclonal, (Baudoux 
et al., 1995)).  
Cells - Vero cells (a monkey kidney cell line, ATCC CCL-81) were grown in 
EMEM medium (Biowhittaker) supplemented with L-glutamine and 10% foetal bovine 
serum (Biowhittaker). ND7 cells (ECACC n° 92090903) were obtained from a fusion 
of murine neuroblastoma cells with primary nerve cells from rat dorsal root ganglia. 
They were grown in RPMI-1640 (Biowhittaker) supplemented with L-glutamine and 
5% foetal bovine serum (Invitrogen) (Wood et al., 1990). 
Cytoplasmic and nuclear protein extracts - Briefly, cells from confluent 175 
cm2 dishes were harvested, washed in cold PBS (137 mM NaCl, 8 mM Na2HPO4, 1.5 
mM KH2PO4, 2.7 mM KCl, pH7.4), pelleted and resuspended in 180 µL of cold 
hypotonic buffer (10mM HEPES-KOH pH7.9, 0.1 mM EDTA 0.1 mM, 10 mM KCl, 2 
mM MgCl2, 1 mM DTT, 0.5 mM PMSF, 0.5% IGEPAL and protease inhibitors 
[Complete Protease Inhibitors, Roche Molecular Biochemicals]). The cells were then 
incubated for 15 min on ice, vortexed 10 s and centrifuged 30 s at 14.000 rpm.  The 
supernatants corresponding to cytoplasmice extract were stored at –80°C. The 
pellets were resuspended in 120 µL of hypertonic buffer containing 50 mM HEPES-
KOH pH 7.9, 50 mM KCl, 300 mM NaCl, 1 mM DTT, 0.5 mM PMSF and protease 
inhibitors [Complete Protease Inhibitors, Roche Molecular Biochemicals]). Cells were 
allowed to swell on ice for 30 min. After centrifugation (15 min at 20,000 g at 4 °C), 
the supernatants containing the nuclear proteins were stored at –80 °C. Protein 
concentrations were measured by the Bradford method (reagent from Biorad). 
Total cellular protein extracts (RIPA lysis) and Western blot analysis - 
Total cellular extracts from Vero cells were obtained by RIPA lyses. Briefly, cells from 
35-mm diameter six-wells cluster dishes were harvested, washed in PBS (137 mM 
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NaCl, 8 mM Na2HPO4, 1.5 mM KH2PO4, 2.7 mM KCl, pH7.4), pelleted and 
resuspended in 200 µL of RIPA lyses buffer (PBS supplemented with 1% Nonited P-
40, 0.5% Tween 20, 0.1% (w/v) SDS, 5 mM EDTA, 1 mM dithiothreitol, and protease 
inhibitors [Complete protease inhibitors, Roche Molecular Biochemicals]). Cells were 
allowed to swell on ice for 30 min, vortexed, then transferred on ice for an additional 
30 min, and centrifuged 20 min at 20,000 x g at 4 °C. Protein concentrations of the 
supernatants were measured by the Bradford method (reagent from Biorad) and 
analyzed by western blotting (15 µg of protein was loaded).  
 Transient transfection assays - Transfections were carried out with cells 
(Vero or ND7) seeded into 35-mm diameter six-wells cluster dishes using the 
FUGENE 6 transfectant reagent according to the manufacturer’s prescriptions 
(Roche Molecular Biochemicals). For each experiment, cells were co-transfected with 
2 µg of luciferase reporter plasmids and 0 to 3 µg of IE63 plasmid expression 
(pcDNA-IE63) The amounts of DNA were adjusted with herring sperm DNA. Special 
attention was made to obtain an equimolar ratio of CMV promoters in each 
independent experiment. Twenty-four hours post-transfection, cells were harvested 
and Luciferase assays were performed using the “Luciferase Reporter Gene Assay, 
high sensitivity” kit (Roche Molecular Biochemicals), according to the instructions of 
the manufacturer. For each experiment, the concentration of proteins in each sample 
was measured in order to normalize the results. Data from luciferase assays were 
collected from at least three independent transfection experiments. P values were 
calculated using graphpad quickcalcs software (www.graphpad.com). To compare 
observed and expected means, one sample t-test was used. For comparison of two 
means, unpaired t-test was chosen. For western-blot analysis, 15 µg of protein 
extracts (RIPA lysis) were loaded on a 10% SDS-PAGE gel. After migration and 
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transfer, detection of IE63 was made using a monoclonal antibody as previously 
described (Bontems et al., 2002, Kennedy et al., 2001). 
Confocal microscopy – Cells, transfected by pcDNA-IE63 grown on 
coverslips were rinsed with warmed PBS and fixed with 4% (w/v) 
paraformaldehyde/PBS for 10 min at room temperature and 20 min at 37 °C. After 
washing with PBS, the cells were permeabilized with PBS containing 0.1 % Triton X-
100 for 10 min at room temperature and 20 min at 37 °C. Cells were then incubated 
with a rabbit serum anti-TFIIE endogenous and a monoclonal antibody anti-IE63 
(9A12) (Debrus et al., 1995) (to detect IE63wt, IE63 ∆1-75, IE63 ∆76-150 and IE63 
∆151-213) or monoclonal antibody anti c-myc (for detection of IE63∆214-278) in PBS 
+ 1% fetal bovine serum (FBS) for 1 hour at 37 °C. After washing with PBS + FBS 
1%, coverslips were incubated with FITC-conjugated anti-rabbit secondary antibodies 
(DAKO A/S, Denmark) and a Texas Red-conjugated anti-mouse secondary antibody 
(Molecular Probes, Leiden, The Netherlands) for 1 hour at 37 °C. For IE62 and IE63 
staining, cells were first co-transfected with the same amount of expression plasmids 
pcDNA-IE62 and pcDNA-IE63. To detect IE62, polyclonal antibody was used and 
then FITC-conjugated anti-rabbit secondary antibodies (DAKO A/S, Denmark). The 
staining for IE63 was the same as described above. Following a PBS rinse, 
coverslips were mounted with SlowFade Light Anti-fade reagent (Molecular Probes, 
Leiden, The Netherlands). Confocal microscopy analyses were performed with a TCS 
SP confocal microscope (Leica) as described previously (Vanderplasschen et al., 
2000). Pictures were collected using a 63x0.9HCX APO L objective and electronic 
amplifications giving rise to square pictures corresponding to 39.7 x 39.7 µm of the 
specimen. Cross-talking was avoided by sequential acquisition of the green and the 
red signals and by setting appropriate spectral windows. The absence of cross-
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talking between channels was demonstrated by the analysis of single positive 
specimens (data not shown). 
PIC assembly assays - A 70 bp of HSV-1 gC (UL44) promoter and a 100 bp 
IL-8 promoter were synthesized and biotinylated (Eurogentec, Belgium) on the 5' 
end. The purified biotinylated promoters were then immobilized on a magnetic resin 
conjugated with streptavidin (Dynal) at 10 µg of DNA biotinylated per 200 µg of beads 
by assay. A 175 cm2 T-flask containing cells was transfected with 24 µg of plasmids 
(pcDNA3.1-, pcDNA-IE63wt). Cells were treated for a period of 36 hours with G418 
(1mg ml-1) (In Vitrogen) in order to select only the transfected cells. About 500 µg of 
the total cell extracts (estimated by the Bradford assay) either containing IE63 protein 
or not was added to 50 µg of immobilized promoters in 400 µL of binding buffer as 
described by (Grondin and DeLuca, 2000). The samples were then incubated for 1 
hour at room temperature on a rotating mixer. After incubation, the immobilized 
templates with the proteins were concentrated with a magnetic concentrator (Dynal), 
resuspended and washed 5 times in 400 µL of binding buffer. The whole samples 
were finally analyzed by western blotting and silver staining (Invitrogen, SilverXpress) 
after SDS-PAGE 10 or 12% gels. Silver-stained gels densitometry was done using 
ImageQuant software. 
Immunoprecipitations – Mouse monoclonal antibody against IE63 (9A12, 
30 µl) and 30 µl of protein A-Sepharose (Amersham Pharmacia Biotech) were 
incubated in buffer C (Yamamoto et al., 2001) (20 mM Tris-HCl [pH 7.9 at 4°C], 
0.5 mM EDTA, 20% [vol/vol] glycerol, 0.5 mM PMSF, 10 mM 2-mercaptoethanol, 
0.002% [vol/vol] Nonidet P-40) containing 100 mM KCl (BC100) and 200 µg of bovine 
serum albumin (BSA)/ml for 2 h at 4°C with rotation. The protein A-Sepharose beads 
were precipitated and washed twice with 1 mL of buffer C containing 0.5 M KCl 
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(BC500) and twice again with 1 ml of BC100. ND7 cells transfected with pcDNA-
IE63-IRES-EGFP or with pcDNA-IRES-EFGP were lysed with protocole lysis using 
Buffer I and buffer II (described above, extract) containing 20% of glycerol. About 400 
µg of cellular extracts were then incubated with the prepared anti-IE63 antibody-
protein A beads in a 1.5 mL of BC500 overnight at 4°C with rotation. The beads were 
washed three times with 1 mL of BC500 and boiled in SDS sample buffer. Then the 
immunoprecipitated proteins released from the beads were analyzed by Western 
blotting. The membranes were either cut into several pieces before being incubated 
with the various antibodies or reprobed. 
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Table 1. Synthesis of VZV IE63 effect on all promoters tested.  
A. Schematic representation of VZV (IE4, p4-Luc; DNA polymerase, pPOL-Luc; 
gC, p67-Luc; IE63, p63-Luc and p63(163bp)-Luc; ORF66, p66-Luc) and 
heterologous (HSV-1 gC, pEL-Pgc-Luc; CMV IE, pCMV-Luc, pFR-Luc, human DNA 
polymerase alpha, ph.POLα-Luc; human IL-8, pIL-8-Luc) promoters tested.  
 
B. Computer analysis of TATA-boxes mapped for all promoters using three 
different programs: Fruitfly.org (http://www.fruitfly.org/seq_tools/promoter.html), 
TFIIbind (http://tfbind.ims.u-tokyo.ac.jp) and Transfac (http://motif.genome.jp). For 
p63-Luc, the computer analysis score corresponds to the first TATA-box 
(TTATTCATAGA). The percentage of IE63 repression obtained on each promoter in 
Vero or ND7 cells transfected with 3 µg of pcDNA-IE63 and 2 µg of reporter plasmid 
is shown (right part). The results shown are the average obtained with a minimum of 




Figure 1. Effect of VZV IE63 protein on the basal activity of VZV promoters. 
(A) Schematic sequence organization of VZV ORF4 (p4-Luc), ORF28 (pPOL-Luc), 
ORF67 (p67-Luc) and ORF63 (p63-Luc and p63(163bp)-Luc) promoters used as 
reporter plasmids. The arrows indicate the transcription start sites and the previously 
mapped TATA-box are framed. Luciferase gene ATG position is circled. The reporter 
plasmid p63-Luc contains IE63 full length promoter. ORF63 promoter contains two 
potential transcription start sites (cloned into p63-Luc) located at positions –88 and –
157 relative to the ORF63 ATG. These two potential TATA-boxes, proposed by these 
authors are TATAAA and TTATTCATAGA. p63(163bp)-Luc vector encompasses 
only the first TATA-box (TTATTCATAGA) and contains 163 bp relative to the ORF63 
ATG. Known upstream regulatory elements (Kinchington et al., 1995) are shown, on 
IE4 promoter: SP1 binding site (GC box) and CAAT (CAAT box) binding site.  
(B), (C) and (D). Effect of VZV IE63 protein on VZV IE4 promoter (p4-Luc), VZV DNA 
polymerase promoter (ORF28, pPOL-Luc), VZV gI promoter (p67-Luc) and VZV 
ORF63 promoter (p63-Luc and p63(163bp)-Luc). Vero (B, D) or ND7 (C) cells were 
co-transfected with luciferase reporter plasmids and increasing concentrations of 
plasmids expressing IE63 (pcDNA-IE63) as described in the material and methods 
section. Results are presented in percentage of stimulation with respect to the basal 
expression of the promoter used (100%). At least three independent experiments 
were conducted for each condition and standard errors of the mean are shown as 
error bars. The expression of IE63 protein was confirmed by western blotting (Figure 
1B, 1C and 1D, lower part). =p value<0.002; = p value≥0.002. 
 
 37 
Figure 2. Effect of IE63 protein on heterologous promoters. 
(A) The sequence organization of CMV (IE) and HSV-1 UL44 promoters used as 
reporter plasmids are shown. The arrows indicate the transcription start sites and the 
previously mapped TATA-box.  
(B) Effect of VZV IE63 protein on CMV (major IE) and HSV-1 UL44 (gC) promoters. 
Vero (B) or ND7 (C) cells were co-transfected with reporter plasmids (pCMV-Luc or 
pEL-Pgc-Luc) and an increasing concentration of plasmid expressing IE63 (pcDNA-
IE63). Results are presented in percentage of stimulation with respect to the basal 
expression of the promoter used (100%). At least three independent experiments 
were conducted for each condition. Standard errors of the mean are shown as error 
bars. =p value<0.002; = p value≥0.002. 
 
 
Figure 3. Importance of the TATA-box and upstream elements for IE63 repressive 
activity.  
(A). Schematic sequence organization of a promoter containing only a TATA-Box 
element (pFR-Luc), a TATA-box-less promoter (the human DNA polymerase alpha, 
ph. POLα-Luc) and the human interleukin-8 promoter (pIL-8-Luc) reporter plasmids. 
The arrows indicate the transcription start sites and the previously mapped TATA-
box. Several known upstream regulatory elements of human DNA polymerase alpha 
and IL-8 promoters are shown: AP-1, AP-2, E2F, SP1 binding site (GC box), ATF, 
CAAT (CAAT box) binding sites and AP-1, NF-IL-6, Oct-1, NF-κB binding sites, 
respectively.  
(B) and (C). VZV IE63 protein regulation on the basal activity of the pFR-Luc and 
ph.POLα-Luc. Vero or ND7 cells were co-transfected with reporter plasmids: pFR-
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Luc (B) or ph.POLα-Luc (C) and with 1 to 3 µg of plasmids pcDNA-IE63. Results are 
presented as percentage of stimulation with respect to the basal expression of the 
promoter used (100%). At least three different experiments were conducted and 
standard errors of the mean are shown as error bars. 
(D). IE63 effects on the pIL-8-Luc. Vero cells were co-transfected with 2 µg of 
reporter plasmids (pIL-8-Luc, pIL-8-NF-κB-mut-Luc, pIL-8-NF-IL-6-mut-Luc or pIL-8-
AP-1-mut-Luc) and 1, 2, and 3 µg of pcDNA-IE63. 24 hours post-transfection, cells 
were harvested and luciferase assays were performed. Results are presented as 
percentage of stimulation with respect to the basal expression of the promoter used 
(100%). At least three different experiments were conducted. =p value<0.002; 
= p value≥0.002. 
 
Figure 4. Mapping of VZV IE63 protein repressive properties. 
(A). Schematic representations of IE63 wild-type and four IE63 deletion constructs 
(IE63 ∆1-75, IE63 ∆76-150, IE63 ∆151-213 and IE63 ∆214-218). Two prediction 
phosphorylation sites for CDK1 and the NLS (black box) are shown. Amino-acids 151 
to 278 contain potential sites for cellular kinases (CK1, CK2 and CDK1). 
(B) and (C). Expression of wild type and mutated IE63 in Vero (B) or ND7 (C) cells 
was analyzed by western blotting. Vero or ND7 cells were co-transfected with 2 µg of 
reporter plasmids (pPOL-Luc) with 1, 2, and 3 µg of plasmids pcDNA-IE63 wild-type 
or deletion constructs. Cells were harvested and then a RIPA lysis was done. Cellular 
protein extracts were loaded on a 10% SDS-PAGE gel. After migration and transfer 
on a PVDF membrane, IE63 proteins were detected using a polyclonal antibody. 
Secondary antibodies used were coupled to peroxidase. The membranes were then 
revealed with ECL kit (Amersham Pharmacia). 
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(D) and (E). Vero and ND7 cells were co-transfected with VZV DNA polymerase 
promoter reporter plasmid (pPol-Luc) with 1-3 µg of plasmids pcDNA-IE63 wild type 
or deletion constructs (pcDNA-IE63wt, pcDNA-IE63∆1-75, pcDNA-IE63∆76-150, 
pcDNA-IE63∆151-213, pcDNA-IE63∆214-278) constructs. Results are presented as 
percentage of stimulation with respect to the basal expression of the promoter 
(reporter alone=100%). Three different experiments or more were conducted, and 
standard errors of the mean are shown as error bars. 
 
Figure 5. Confocal microscopy analysis of wild-type and deleted IE63 proteins in 
Vero and ND7 cells. 
Vero and ND7 cells were transfected with 2 µg of plasmids expressing either wild-
type (A,B) or mutant IE63 (C, D, E, and F) and then fixed before being incubated with 
antibodies against IE63 and TFIIE. Confocal microscopy analysis was performed 
after incubation with anti-IE63 or anti-TFIIE antibodies and staining with Texas Red- 
or FITC-conjugated secondary antibodies, respectively. Vero (G) and ND7 (H) cells 
were co-transfected with the same amount of pcDNA-IE62 and pcDNA-IE63. 
Polyclonal antibody directed against IE62 and monoclonal antibody directed against 
IE63 were used. Then a staining with anti-mouse Texas Red- (showing IE63 in red) 
or anti-rabbit FITC- (showing IE62 in green) conjugated secondary antibody was 
performed. These images were merged to study co-localization.  
 
Figure 6. Effect of VZV IE63 on the pre-initiation complex formation in ND7 cells. 
Cells were transfected with pcDNA3.1- or with pcDNA-IE63 wild type or mutated. 
Nuclear extracts were incubated for 1h with immobilized HSV-1 gC promoters (as 
described in the experimental procedures). The assembled PIC was then washed 
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and the proteins bound onto the promoters were analyzed by SDS-PAGE and 
subsequent silver-staining (A) or western blotting (B).  
(A). Silver stained SDS-PAGE analysis. Molecular weight corresponding to SDS6H-
1VL (Sigma) is indicated, Lane 1: PIC assembly with extracts from ND7 transfected 
with pcDNA3.1, Lane 2: PIC assembly with extracts from ND7 transfected with 
pcDNA-IE63. Arrow points indicate a decrease in staining when lane 2 was 
compared to lane 1. Putative corresponding GTFs are shown next to the arrows. 
Stars correspond to proteins whose amounts are unchanged by IE63. 
(B). The presence of the RNA POL II largest subunit (POLR2A), TFIIEα, TFIIH, TBP, 
TFIIB and IE63 after PIC assembly on the gC probe with extracts from ND7 
transfected with pcDNA3.1- (lane 1) and from ND7 transfected with pcDNA-IE63 
(lane 2) were assessed by Western blotting analysis. The unbound extracts were 
used as a positive control (lane 3). 
(C) The presence of TFIIEα, TBP and TFIIB after PIC assembly with extracts from 
ND7 transfected with pcDNA3.1 (lane 1), pcDNA-IE63 (lane 2), pcDNA-IE63∆151-
213 (lane 3) or pcDNA-IE63∆214-278 (lane 4) were assessed by Western blotting 
analysis. The excess of extracts that were not bound to the gC promoter was used as 
positive control (lane 5). 
(D). The expression levels of IE63 (wild type or mutated forms) and of TFIIEα were 
verified by western blot (12% SDS-PAGE) of extracts from ND7 transfected with 
pcDNA-IE63wt (lane 1), pcDNA-IE63∆151-213 (lane 2), pcDNA-IE63∆214-278 (lane 
3) and pcDNA3.1- (lane 4). 
(E). Immunoprecipitation of IE63 protein. Immunoprecipitation was performed in a 
175 cm2 T-flask of ND7 transfected with 12 µg of pcDNA-IE63-IRES2-EGFP (lane 1) 
or pcDNA-IRES2-EGFP (lane 2). IE63 protein was immunoprecipitated using an IE63 
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monoclonal antibody (9A12). After washing, immunoprecipitated proteins were 
loaded on 10% SDS PAGE and western blotting analysis was carried out with 
antibodies directed against POLR2A, TFIIEα, TFIIH and IE63. 
(F). Immunoprecipitation of TFIIH from ND7 cells transfected with 12 µg of pcDNA-
IE63-IRES2-EGFP. After washing, immunoprecipitated proteins were analyzed by 
western blotting with the IE63 monoclonal antibody (9A12). 
 
Figure 1
Figure 2
Fi 3gure 
Figure 4
Figure 5
Figure 6
Table 1
